• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

    10/17/23 1:42:48 PM ET
    $AGBA
    $AGRI
    $AMAM
    $ANEB
    Investment Managers
    Finance
    Metal Fabrications
    Industrials
    Get the next $AGBA alert in real time by email

    Gainers

    • SciSparc Ltd. (NASDAQ:SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million private placement for SciSparc.
    • Assembly Biosciences, Inc. (NASDAQ:ASMB) gained 120% to $1.5982 after the company and Gilead announced they entered into a 12-year partnership to advance the research and development of novel antiviral therapies.
    • Olink Holding AB (NASDAQ:OLK) shares climbed 65.8% to $24.84 after Thermo Fisher Scientific announced it will acquire the company.
    • MoneyHero Limited (NASDAQ:MNY) surged 33.7% to $3.40.
    • OpGen, Inc. (NASDAQ:OPGN) gained 32.7% to $1.20.
    • FLJ Group Limited (NASDAQ:FLJ) jumped 29.3% to $0.2689.
    • Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) gained 22.5% to $2.0950.
    • Ramaco Resources, Inc. (NASDAQ:METC) rose 20.2% to $11.73.
    • Aurora Mobile Limited (NASDAQ:JG) shares climbed 19.8% to $0.1593 after gaining 8% on Monday.
    • Nkarta, Inc. (NASDAQ:NKTX) rose 18.5% to $1.75 as the company received FDA clearance of IND application for NKX019 in lupus nephritis.
    • AgriFORCE Growing Systems Ltd. (NASDAQ:AGRI) gained 18% to $3.0905.
    • Gamer Pakistan Inc. (NASDAQ:GPAK) gained 16.8% to $1.46.
    • Summit Therapeutics Inc. (NASDAQ:SMMT) rose 16% to $2.03.
    • Meiwu Technology Company Limited (NASDAQ:WNW) shares rose 15.4% to $0.1062 after falling 4% on Monday.
    • WiSA Technologies, Inc. (NASDAQ:WISA) shares gained 12.8% to $0.28 after falling 40% on Monday. WiSA Technologies announced pricing of $4.8 million public offering of Series B convertible redeemable preferred stock and warrants.
    • iTeos Therapeutics, Inc. (NASDAQ:ITOS) jumped 12.8% to $9.77.
    • Athersys, Inc. (NASDAQ:ATHX) shares gained 12.3% to $0.1102. Athersys extended near term liquidity with proceeds from warrant inducement and global ARDS license with Healios to explore strategic alternatives.
    • Moolec Science SA (NASDAQ:MLEC) climbed 12% to $2.80. Moolec Science secured $21 million investment from Grupo Insud, bolstering its food ingredient innovations.
    • V.F. Corporation (NYSE:VFC) gained 10.1% to $17.82. Engaged Capital has built a big stake in VF Corp, according to the Wall Street Journal.
    • AGBA Group Holding Limited (NASDAQ:AGBA) rose 8.9% to $0.5336.
    • Cytek Biosciences, Inc. (NASDAQ:CTKB) gained 8.6% to $5.24.
    • Under Armour, Inc. (NYSE:UAA) rose 7.3% to $7.51.

    Losers

    • Evelo Biosciences, Inc. (NASDAQ:EVLO) shares fell 50.2% to $1.4501. Evelo Biosciences released top-line results from its Phase 2 clinical study with EDP2939 in moderate psoriasis.
    • Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) fell 19.9% to $4.0050 as the company announced interim data from the Phase 1 dose escalation part of its ongoing phase 1/2 study of MRT-2359 in patients with MYC-driven solid tumors.
    • Nuvve Holding Corp. (NASDAQ:NVVE) fell 19.1% to $0.3161 after gaining over 9% on Monday.
    • NetScout Systems, Inc. (NASDAQ:NTCT) fell 18.2% to $22.58 after the company reported weak preliminary results for the second quarter and lowered its FY24 guidance.
    • BIO-key International, Inc. (NASDAQ:BKYI) fell 17.4% to $0.4299 after the company filed for offering of units of up to $10 million.
    • Bio-Path Holdings, Inc. (NASDAQ:BPTH) declined 16.5% to $0.5678.
    • Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) fell 10.4% to $1.2187.
    • DXC Technology Company (NYSE:DXC) fell 9.9% to $20.05 after Wolfe Research downgraded the stock from Peer Perform to Underperform.
    • The Vita Coco Company, Inc. (NASDAQ:COCO) fell 9.7% to $24.29.
    • Ambrx Biopharma Inc. (NASDAQ:AMAM) fell 8.7% to $10.44 after declining 19% on Monday. Ambrx Biopharma announced that two abstracts detailing updated safety and efficacy data from the ongoing Phase 1/2 trial, APEX-01, evaluating ARX517 for metastatic castration-resistant prostate cancer (mCRPC) were made available as part of the 2023 European Society of Medical Oncology Congress 2023 meeting.
    • Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) fell 8.5% to $2.01 after gaining 11% on Monday.
    • Nvni Group Limited (NASDAQ:NVNI) fell 8.4% to $3.18.
    • VMware, Inc. (NYSE:VMW) fell 7% to $166.33.
    • ServisFirst Bancshares, Inc. (NASDAQ:SFBS) declined 6.1% to $49.65 after the company reported third-quarter earnings.
    • 22nd Century Group, Inc. (NASDAQ:XXII) shares fell 5.4% to $0.5201 after the company reported pricing of $5.25 million public offering.
    • NVIDIA Corporation (NASDAQ:NVDA) declined 4.6% to $439.95. The U.S. government divulged plans to halt shipments to China of more advanced AI chips designed by Nvidia and others, citing military threats.
    • The Bank of New York Mellon Corporation (NYSE:BK) fell 4.5% to $39.99 following third-quarter results.
    • Telefonaktiebolaget LM Ericsson (NASDAQ:ERIC) shares fell 3.6% to $4.5899 after the company reported downbeat third-quarter sales. Ericsson expects lower than-normal seasonality in sales between Q3 and Q4 for Networks and Cloud Software and Services.

     

    Now Read This: How To Earn $500 A Month From Charles Schwab Stock Following Q3 Earnings

    Get the next $AGBA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGBA
    $AGRI
    $AMAM
    $ANEB

    CompanyDatePrice TargetRatingAnalyst
    Summit Therapeutics Inc.
    $SMMT
    4/8/2026$45.00Buy
    Stifel
    Summit Therapeutics Inc.
    $SMMT
    3/16/2026$15.00Buy → Hold
    Jefferies
    ServisFirst Bancshares Inc.
    $SFBS
    2/27/2026$92.00 → $97.00Outperform
    Hovde Group
    The Bank of New York Mellon Corporation
    $BK
    2/23/2026Neutral
    Citigroup
    V.F. Corporation
    $VFC
    2/23/2026$18.00Neutral → Underweight
    Analyst
    Under Armour Inc.
    $UAA
    2/10/2026$6.20Neutral → Sell
    Citigroup
    Ericsson
    $ERIC
    2/9/2026$11.00Equal-Weight
    Morgan Stanley
    Under Armour Inc.
    $UAA
    2/9/2026$5.00 → $6.00Market Perform
    Telsey Advisory Group
    More analyst ratings

    $AGBA
    $AGRI
    $AMAM
    $ANEB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Debbane Raymond bought $2,980 worth of shares (2,000 units at $1.49), increasing direct ownership by 0.11% to 1,906,186 units (SEC Form 4)

    4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)

    2/27/26 8:33:21 AM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Debbane Raymond bought $147,000 worth of shares (100,000 units at $1.47), increasing direct ownership by 6% to 1,904,186 units (SEC Form 4)

    4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)

    2/25/26 7:00:27 AM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Debbane Raymond bought $219,755 worth of shares (150,000 units at $1.47), increasing direct ownership by 9% to 1,804,186 units (SEC Form 4)

    4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)

    2/23/26 7:49:43 AM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGBA
    $AGRI
    $AMAM
    $ANEB
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for INPEFA issued to LEXICON PHARMACEUTICALS INC

    Submission status for LEXICON PHARMACEUTICALS INC's drug INPEFA (ORIG-1) with active ingredient SOTAGLIFLOZIN has changed to 'Approval' on 05/26/2023. Application Category: NDA, Application Number: 216203, Application Classification: Type 1 - New Molecular Entity

    5/30/23 10:02:49 AM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    December 23, 2021 - FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

    For Immediate Release: December 23, 2021 Today, the U.S. Food and Drug Administration authorized the marketing of 22nd Century Group Inc.’s “VLN King” and “VLN Menthol King” combusted, filtered cigarettes as modified risk tobacco products (MRTPs), which help reduce exposure to, and consumption of, nicotine for smokers who use them. These are the first combusted cigarettes to be authorized as MRTPs and the second

    12/23/21 9:06:12 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    $AGBA
    $AGRI
    $AMAM
    $ANEB
    SEC Filings

    View All

    SEC Form 144 filed by The Vita Coco Company Inc.

    144 - Vita Coco Company, Inc. (0001482981) (Subject)

    4/8/26 10:39:49 AM ET
    $COCO
    Beverages (Production/Distribution)
    Consumer Staples

    SEC Form 144 filed by The Vita Coco Company Inc.

    144 - Vita Coco Company, Inc. (0001482981) (Subject)

    4/7/26 11:18:00 AM ET
    $COCO
    Beverages (Production/Distribution)
    Consumer Staples

    Nuvve Holding Corp. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Financial Statements and Exhibits

    8-K - Nuvve Holding Corp. (0001836875) (Filer)

    4/6/26 4:31:24 PM ET
    $NVVE
    Electrical Products
    Industrials

    $AGBA
    $AGRI
    $AMAM
    $ANEB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    /C O R R E C T I O N -- Singapore Gulf Bank/

    In the news release, Singapore Gulf Bank Joins BNY's Correspondent Banking Network and Fixed Income Brokerage Platform, issued 07-Apr-2026 by Singapore Gulf Bank over PR Newswire, we are advised by the company that the release has changed throughout. The complete, corrected release follows: Singapore Gulf Bank joins BNY's Correspondent Banking Network MANAMA, Bahrain, April 7, 2026 /PRNewswire/ -- Singapore Gulf Bank (SGB) today announced it has joined the correspondent banking network of BNY (NYSE:BK), a global financial services company, to further strengthen its U.S. dollar clearing capabilities. The relationship adds another leading U.S. dollar clearing provider to SGB's growing set of c

    4/7/26 3:59:00 AM ET
    $BK
    Major Banks
    Finance

    DXC Partners with ServiceNow on a New Wave of AI-first Enterprise Transformation

    DXC adopts ServiceNow's Core Business Suite as Customer Zero, activating agentic AI across core business functions for a Global Business Services-led transformation The partnership combines DXC's transformation expertise with the ServiceNow AI Platform to power smarter, more resilient operations across the enterprise DXC will enable customers to replicate these transformation outcomes at scaleASHBURN, Va., April 7, 2026 /CNW/ - DXC Technology (NYSE:DXC), a leading enterprise technology and innovation partner, and ServiceNow, the AI control tower for business reinvention, today announced a new, multi-year agreement to modernize core enterprise operations and put AI to work at scale. The partn

    4/7/26 9:00:00 AM ET
    $DXC
    EDP Services
    Technology

    AI-Driven Compliance Gamechanger in Pharma Manufacturing and Regulatory Standards

    AUSTIN, Texas, April 07, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: As regulatory expectations intensify and manufacturing complexity grows, pharmaceutical companies are moving beyond traditional quality systems toward a new paradigm: embedding artificial intelligence (AI) directly into operations as a real-time compliance layer. Rather than relying on retrospective audits and manual oversight, AI-driven systems now continuously monitor, validate and optimize production processes to align with evolving Good Manufacturing Practice (GMP) standards. This structural shift is increasingly visible across the industry and aligns with companies such as Oncotelic Therapeutics Inc. (OTC

    4/7/26 8:30:00 AM ET
    $AMZN
    $HON
    $NVDA
    Catalog/Specialty Distribution
    Consumer Discretionary
    Aerospace
    Industrials

    $AGBA
    $AGRI
    $AMAM
    $ANEB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Stifel initiated coverage on Summit Therapeutics with a new price target

    Stifel initiated coverage of Summit Therapeutics with a rating of Buy and set a new price target of $45.00

    4/8/26 8:38:26 AM ET
    $SMMT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Summit Therapeutics downgraded by Jefferies with a new price target

    Jefferies downgraded Summit Therapeutics from Buy to Hold and set a new price target of $15.00

    3/16/26 8:36:55 AM ET
    $SMMT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Hovde Group reiterated coverage on ServisFirst Bancshares with a new price target

    Hovde Group reiterated coverage of ServisFirst Bancshares with a rating of Outperform and set a new price target of $97.00 from $92.00 previously

    2/27/26 8:01:05 AM ET
    $SFBS
    Major Banks
    Finance

    $AGBA
    $AGRI
    $AMAM
    $ANEB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Bowen Matthew

    4 - Monte Rosa Therapeutics, Inc. (0001826457) (Issuer)

    4/7/26 4:10:03 PM ET
    $GLUE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 3 filed by new insider Bowen Matthew

    3 - Monte Rosa Therapeutics, Inc. (0001826457) (Issuer)

    4/7/26 4:05:03 PM ET
    $GLUE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 4 filed by Robinson Elizabeth

    4 - Bank of New York Mellon Corp (0001390777) (Issuer)

    4/3/26 4:10:35 PM ET
    $BK
    Major Banks
    Finance

    $AGBA
    $AGRI
    $AMAM
    $ANEB
    Leadership Updates

    Live Leadership Updates

    View All

    10 Federal Taps Top-Ranked Nvidia AI Engineer to Fill Self-Storage Industry's First Chief AI Officer Role

    Nvidia's top 1% AI engineer leaves world's most valuable company to lead self-storage's first Chief AI Officer role at 10 FederalRALEIGH, N.C., April 6, 2026 /PRNewswire/ -- 10 Federal, a leading technology-driven self-storage owner and operator, today announced the appointment of Christopher Taylor as its Chief A.I. Officer (CAIO), a newly created executive position that represents the first dedicated C-suite AI role in the self-storage industry. Taylor joins 10 Federal from Nvidia (NASDAQ:NVDA), the global leader in AI computing, where he served as a Senior Software Engineer working across both the data center division and the autonomous vehicle platform, and ranked among the top 1% of AI

    4/6/26 6:00:00 AM ET
    $NVDA
    Semiconductors
    Technology

    Rani Therapeutics Appoints Jesper Høiland as Head of Strategy to Advance Corporate and Pipeline Prioritization

    SAN JOSE, Calif., March 25, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. ("Rani Therapeutics" or "Rani") (NASDAQ:RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced the appointment of Jesper Høiland as Head of Strategy. Mr. Høiland has served as a strategic adviser to the company since 2023 and brings more than 30 years of global pharmaceutical leadership experience, including extensive expertise in obesity and metabolic disease. "Jesper is a highly respected leader with a rare combination of strategic insight and deep commercial experience, and we are thrilled to welcome him as Head of Strategy," said Talat Imr

    3/25/26 4:53:16 PM ET
    $RANI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    The Vita Coco Company Set to Join S&P SmallCap 600

    NEW YORK, March 20, 2026 /PRNewswire/ -- The Vita Coco Company Inc. (NASD: COCO) will replace TEGNA Inc. (NYSE:TGNA) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, March 25. S&P MidCap 400 constituent Nexstar Media Group Inc. (NASD: NXST) has acquired TEGNA in a deal that closed today, March 20. Following is a summary of the change that will take place prior to the open of trading on the effective date:Effective DateIndex Name       ActionCompany NameTickerGICS SectorMarch 25, 2026S&P SmallCap 600AdditionThe Vita Coco CompanyCOCOConsumer StaplesMarch 25, 2026S&P SmallCap 600DeletionTEGNATGNACommunication ServicesABOUT S&P DOW JONES INDICESS&P Dow Jones Indice

    3/20/26 6:06:00 PM ET
    $COCO
    $NXST
    $SPGI
    Beverages (Production/Distribution)
    Consumer Staples
    Broadcasting
    Industrials

    $AGBA
    $AGRI
    $AMAM
    $ANEB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Nkarta Inc.

    SC 13G - Nkarta, Inc. (0001787400) (Subject)

    12/13/24 5:02:47 PM ET
    $NKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Lexicon Pharmaceuticals Inc.

    SC 13D/A - LEXICON PHARMACEUTICALS, INC. (0001062822) (Subject)

    12/9/24 9:33:20 PM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by 22nd Century Group Inc.

    SC 13G/A - 22nd Century Group, Inc. (0001347858) (Subject)

    12/3/24 11:18:54 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    $AGBA
    $AGRI
    $AMAM
    $ANEB
    Financials

    Live finance-specific insights

    View All

    BNY Mellon Municipal Bond Infrastructure Fund, Inc. (NYSE: DMB) Announces Distribution

    BNY Mellon Municipal Bond Infrastructure Fund, Inc. (NYSE:DMB) today announced a distribution of $0.0420 per share of common stock, payable on May 1, 2026 to shareholders of record at the close of business on April 17, 2026. The ex-dividend date is April 17, 2026. The previous distribution announced in March was $0.0420 per share of common stock. The Fund intends to make regular monthly distributions to its common shareholders at a level rate based on its projected performance. At times, to maintain a stable level of distributions, the Fund may pay out less than all of its net investment income or, in addition to paying out current net investment income, the Fund may pay out accumulated u

    4/2/26 4:12:00 PM ET
    $BK
    $DMB
    Major Banks
    Finance
    Trusts Except Educational Religious and Charitable

    BNY 2026 Annual Meeting of Stockholders

    NEW YORK, April 2, 2026 /PRNewswire/ -- As previously announced, The Bank of New York Mellon Corporation ("BNY") (NYSE:BK), a global financial services company, will hold the 2026 Annual Meeting of Stockholders on Tuesday, April 14, 2026, at 9:00 a.m. ET. The Notice of Annual Meeting and Proxy Statement was made available on March 5, 2026. The Annual Meeting will be held virtually, and a live webcast will be available at www.virtualshareholdermeeting.com/BK2026. This webcast may include forward-looking statements and other material information. Stockholders can participate, vote

    4/2/26 9:00:00 AM ET
    $BK
    Major Banks
    Finance

    Ericsson's Annual General Meeting 2026

    STOCKHOLM, March 31, 2026 /PRNewswire/ -- Telefonaktiebolaget LM Ericsson (NASDAQ:ERIC) (the "Company") held its Annual General Meeting ("AGM") today on March 31, 2026 in Kista, Stockholm. Shareholders were also able to exercise their voting rights by post before the meeting. Adoption of the Income Statements and the Balance SheetsThe AGM resolved to adopt the Income Statement and the Balance Sheet for the Company as well as the Consolidated Income Statement and the Consolidated Balance Sheet for the Group for 2025.DividendThe proposed dividend of SEK 3.00 per share was approved by the AGM. The dividend will be paid in two installments: SEK 1.50 per share with the record date April 2, 2026,

    3/31/26 12:41:00 PM ET
    $ERIC
    Radio And Television Broadcasting And Communications Equipment
    Technology